Clinical Management Department, Institut Català d'Oncologia, Barcelona, Spain.
Radiation Oncology Department, Institut Català d'Oncologia, Girona, Spain.
Radiat Oncol. 2020 Jan 31;15(1):28. doi: 10.1186/s13014-020-1465-z.
Colorectal cancer treatment requires a complex, multidisciplinary approach. Because of the potential variability, monitoring through clinical audits is advisable. This study assesses the effects of a quality improvement action plan in patients with locally advanced rectal cancer and treated with radiotherapy.
Comparative, multicentre study in two cohorts of 120 patients each, selected randomly from patients diagnosed with rectal cancer who had initiated radiotherapy with a curative intent. Based on the results from a baseline clinical audit in 2013, a quality improvement action plan was designed and implemented; a second audit in 2017 evaluated its impact.
Standardised information was present on 77.5% of the magnetic resonance imaging (MRI) staging reports. Treatment strategies were similar in all three study centres. Of the patients whose treatment was interrupted, just 9.7% received a compensation dose. There was an increase in MRI re-staging from 32.5 to 61.5%, and a significant decrease in unreported circumferential resection margins following neoadjuvant therapy (ypCRM), from 34.5 to 5.6% (p < 0.001).
The comparison between two clinical audits showed improvements in neoadjuvant radiotherapy in rectal cancer patients. Some indicators reveal areas in need of additional efforts, for example to reduce the overall treatment time.
结直肠癌的治疗需要采用复杂的多学科方法。由于潜在的可变性,通过临床审核进行监测是明智的。本研究评估了质量改进行动计划对接受放射治疗的局部晚期直肠癌患者的影响。
这是一项在两个队列中进行的比较性、多中心研究,每个队列随机选择了 120 名接受根治性放射治疗的直肠癌患者。基于 2013 年基线临床审核的结果,设计并实施了质量改进行动计划;2017 年进行了第二次审核,评估其影响。
磁共振成像(MRI)分期报告中,有 77.5%的报告提供了标准化信息。所有三个研究中心的治疗策略相似。治疗中断的患者中,仅有 9.7%接受了补偿剂量。MRI 重新分期从 32.5%增加到 61.5%,新辅助治疗后未报告的环周切缘阳性(ypCRM)从 34.5%显著下降至 5.6%(p<0.001)。
两次临床审核的比较显示,直肠癌患者的新辅助放疗有所改善。有些指标显示出需要进一步努力的领域,例如减少整体治疗时间。